Proliferative potential of malignant glioma cells before and after interstitial brachytherapy

Neurologia Medico-Chirurgica

Volumn 39, Issue 5, 1999, Pages 341-349

  Kunishio, Katsuzo ^a,b   Matsumoto, Kengo ^a   Higashi, Hisato ^a   Adachi, Hisashi ^a   Tamiya, Takashi ^a   Furuta, Tomohisa ^a   Ohmoto, Takashi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

Interstitial brachytherapy; Malignant glioma; MIB 1; Radionecrosis

Indexed keywords

BROXURIDINE; CARBOPLATIN; CYCLINE; DNA DIRECTED DNA POLYMERASE ALPHA; INTERFERON; IODINE 125; IRIDIUM 192; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; NIMUSTINE; RANIMUSTINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER SURVIVAL; CELL VIABILITY; CHILD; CLINICAL ARTICLE; CRANIOTOMY; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL RADIATION; MALE; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION NECROSIS; REOPERATION; STEREOTAXIC SURGERY; TUMOR RECURRENCE;

EID: 0033017779     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.39.341     Document Type: Article

References (30)

1. Arbit E, Shapiro JR, Fiola M, Malkin MG, Galicich JH: The significance of morphologically viable glioma cells found at the time of operation after interstitial brachytherapy. Neurosurgery 32: 105-110, 1993
2. Bernstein M, Gutin PH: Interstitial irradiation of brain tumors: a review. Neurosurgery 9: 741-750, 1981
3. Burger PC, Shibata T, Kleihues P: The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 10: 611-617, 1986
4. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle C, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168: 357-363, 1992
5. Forsyth PA, Kelly PJ, Cascino TL, Scheithauer BW, Shaw EG, Dinapoli RP, Atkinson EJ: Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful? J Neurosurg 82: 436-444, 1995
6. Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710-1715, 1984
7. Gutin PH, Bernstein M: Stereotactic interstitial brachytherapy for malignant brain tumors. Prog Exp Tumor Res 28: 166-182, 1984
8. Gutin PH, Leibel SA: Stereotactic interstitial irradiation of malignant brain tumors. Neurol Clin 3: 883-893, 1985
9. Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL, Silver P, Da Silva V, Edwards MSB, Davis RL, Weaver KA, Lamb S: Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 67: 864-873, 1987
10. Higashi H, Matsumoto K, Ono Y, Shinohara C, Nakagawa M, Tsuno K, Furuta T, Ohmoto T: [Patterns of recurrence in malignant gliomas after brachytherapy]. No Shinkei Geka 22: 321-326, 1994 (Jpn, with Eng abstract)
11. Hohwieler ML, Lo TMC, Silverman ML, Freiberg SR: Brain necrosis after radiotherapy for primary intracerebral tumor. Neurosurgery 18: 67-72, 1986
12. Hosobuchi Y, Phillips TL, Stupar TA, Gutin PH: Interstitial brachytherapy of primary brain tumors: Preliminary report. J Neurosurg 53: 613-617, 1980
13. Karamitopoulou E, Perentes E, Melachinou M, Maraziotis T: Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol (Berl) 85: 316-322, 1993
14. Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad H-D, Gerdes J: New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterally expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68: 629-636, 1993
15. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System, ed 2. Berlin, Springer-Verlag, 1993, pp 11-30
16. Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD: Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms. Neurosurgery 41: 776-785, 1997
17. Kunishio K, Mishima N, Matsuhisa T, Tsuno K, Matsumi N, Satoh T, Matsumoto K, Furuta T, Nishimoto A, Shiraishi T: Immunohistochemical demonstration of DNA polymerase alpha human brain tumor cells. J Neurosurg 72: 268-272, 1990
18. Marks JE, Wong J: The risk of cerebral radionecrosis in relation to dose, time and fractionation. A follow-up study. Prog Exp Tumor Res 29: 210-218, 1985
19. 192Ir brachytherapy for malignant gliomas. Neurol Med Chir (Tokyo) 32: 739-746, 1992
20. Matsumoto K, Nakagawa T, Tada E, Furuta T, Hiraki Y, Ohmoto T: Effect of adjuvant iridium-192 brachytherapy on the survival of patients with malignant gliomas. Neurol Med Chir (Tokyo) 37: 891-900, 1997
21. Mundinger F, Birg W, Ostertag CB: Treatment of small cerebral gliomas with CT-aided stereotactic Curietherapy. Neuroradiology 9: 564-567, 1987
22. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T: Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 74: 1921-1926, 1994
23. Prados MD, Gutin PH, Phillips TL, Wara WM, Sneed PK, Larson DA, Lamb SA, Ham B, Malec MK, Wilson CB: Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys 24: 593-597, 1992
24. Sarkaria JN, Mehta MP, Loeffler JS, Buatti JM, Chappell RJ, Levin AB, Alexander EA III, Friedman WA, Kinsella TJ: Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys 32: 931-941, 1995
25. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, Weaver KA, Malec M, Acord P, Lamborn KR, Lamb SA, Ham B, Gutin PH: High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 24: 583-591, 1992
26. Sheline GE: Normal tissue tolerance and radiation therapy of gliomas of the adult brain, in Bleehen NM (ed): Tumours of the Brain. Berlin, Heidelberg, New York, Springer, 1986, pp 141-160
27. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T: Proliferative potential of brain tumors: Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer 71: 199-206, 1993
28. Shrieve DC, Alexander E III, Wen PY, Fine HA, Kooy HM, Black PM, Loeffler JS: Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 36: 275-284, 1995
29. Siddiqi SN, Provias J, Laperriere N, Bernstein M: Effect of iodine-125 brachytherapy on the proliferative capacity and histopathological features of glioblastoma recurring after initial therapy. Neurosurgery 40: 910-918, 1997
30. Wowra B, Schmitt HP, Sturm V: Incidence of late radiation necrosis with transient mass effect after interstitial low dose rate radiotherapy for cerebral gliomas. Acta Neurochir (Wien) 99: 104-108, 1989